Literature DB >> 22987139

Influence of stearic acids on resveratrol-HSA interaction.

Manuela Pantusa1, Luigi Sportelli, Rosa Bartucci.   

Abstract

The interaction between the natural polyphenol resveratrol and human serum albumin (HSA), the most abundant transport protein in plasma, has been studied in the absence and in the presence of up to six molecules of stearic acids (SA) pre-complexed with the protein. The study has been carried out by using the intrinsic fluorescence of both HSA and resveratrol. Protein and polyphenol fluorescence data indicate that resveratrol binds to HSA with an association constant k(a) = (1.10 ± 0.14) × 10(5) M(-1) and (1.09 ± 0.02) × 10(5) M(-1), respectively, whereas Job plot evidences the formation of an equimolar protein/drug complex. Low SA content associated with HSA does not affect significantly the structural conformation of the protein and its interaction with resveratrol, whereas high SA content induces conformational changes in the protein, and reduces resveratrol binding affinity. The photostability of resveratrol in the different samples changes in the order: buffer < (high [SA]/HSA) < HSA < (low [SA]/HSA). The results on (SA/HSA)-resveratrol samples highlight the ability of the protein to bind hydrophobic and amphiphilic ligands and to protect from degradation an important antioxidant molecule under biologically relevant conditions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22987139     DOI: 10.1007/s00249-012-0856-y

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  37 in total

1.  Further characterization of specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

2.  Interaction of beta-lactoglobulin with resveratrol and its biological implications.

Authors:  Li Liang; H A Tajmir-Riahi; Muriel Subirade
Journal:  Biomacromolecules       Date:  2007-12-08       Impact factor: 6.988

3.  Analysis of the resveratrol-binding protein using phage-displayed random peptide library.

Authors:  Lei Feng; Jian Jin; Lian-Feng Zhang; Ting Yan; Wen-Yi Tao
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2006-05       Impact factor: 3.848

Review 4.  Resveratrol, a phenolic antioxidant with effects on blood platelet functions.

Authors:  Beata Olas; Barbara Wachowicz
Journal:  Platelets       Date:  2005-08       Impact factor: 3.862

5.  Resveratrol binding to human serum albumin.

Authors:  C N N' soukpoe-Kossi; C St-Louis; M Beauregard; M Subirade; R Carpentier; S Hotchandani; H A Tajmir-Riahi
Journal:  J Biomol Struct Dyn       Date:  2006-12

6.  Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy.

Authors:  H Vorum; B Honoré
Journal:  J Pharm Pharmacol       Date:  1996-08       Impact factor: 3.765

7.  Crystal structure of human serum albumin at 2.5 A resolution.

Authors:  S Sugio; A Kashima; S Mochizuki; M Noda; K Kobayashi
Journal:  Protein Eng       Date:  1999-06

8.  Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy.

Authors:  J R Simard; P A Zunszain; C-E Ha; J S Yang; N V Bhagavan; I Petitpas; S Curry; J A Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

9.  Kinetics of stearic acid transfer between human serum albumin and sterically stabilized liposomes.

Authors:  Manuela Pantusa; Rosa Bartucci
Journal:  Eur Biophys J       Date:  2010-03-20       Impact factor: 1.733

10.  Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I.

Authors:  I Petitpas; A A Bhattacharya; S Twine; M East; S Curry
Journal:  J Biol Chem       Date:  2001-04-02       Impact factor: 5.157

View more
  1 in total

1.  Binding of dihydromyricetin and its metal ion complexes with bovine serum albumin.

Authors:  Qingquan Guo; Juan Yuan; Jinhua Zeng
Journal:  Biotechnol Biotechnol Equip       Date:  2014-07-08       Impact factor: 1.632

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.